COMMUNIQUÉS West-GlobeNewswire
-
Informations relatives au nombre total de droits de vote et d’actions composant le capital
07/10/2026 -
BrewDog’s Winning Streak Rolls on with Gold at the Scottish Beer Awards
07/10/2026 -
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
07/10/2026 -
Alignment Health Expands to Three New California Counties and Adds Hoag and Astrana Health for 2027
07/10/2026 -
Raw Garden Launches a Higher Standard in Distillate All-In-One
07/10/2026 -
Childhood cancer treatment success reaches 87%, says Medicana specialist
07/10/2026 -
DCI Edge Introduces Series 5 Plus Dental Stools with 13° Anterior-Tilt Seat and Patent-Pending Brake
07/10/2026 -
Vystar Announces Formation of New R3ALM Corporation and Progress Toward Live Platform Launch
07/10/2026 -
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
07/10/2026 -
AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays
07/10/2026 -
Optimi Health to Present at the ThinkEquity Conference
07/10/2026 -
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
07/10/2026 -
Integrity Care Group Enters Two New States and Strengthens Core Market with Acquisition of 15 NextCare Clinics; Now Offers Access to High-Quality Healthcare in 100 Clinics Across Five States
07/10/2026 -
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
07/10/2026 -
Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit
07/10/2026 -
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
07/10/2026 -
Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
07/10/2026 -
Commure Appoints Nick Apeland as President of Go-to-Market
07/10/2026 -
Tria Federal Launches Healthcare Trilemma Campaign to Open a New Conversation in Federal Health
07/10/2026
Pages